Cargando…
Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study
BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwis...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676144/ https://www.ncbi.nlm.nih.gov/pubmed/26655187 http://dx.doi.org/10.1186/s12872-015-0165-3 |
_version_ | 1782405120936378368 |
---|---|
author | Nielsen, Mette Lundgren Pareek, Manan Gerke, Oke Leósdóttir, Margrét Nilsson, Peter M. Olsen, Michael Hecht |
author_facet | Nielsen, Mette Lundgren Pareek, Manan Gerke, Oke Leósdóttir, Margrét Nilsson, Peter M. Olsen, Michael Hecht |
author_sort | Nielsen, Mette Lundgren |
collection | PubMed |
description | BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwise healthy males. METHODS: Prospective population-based cohort study with a median (IQR) follow-up time of 28 (27–28) years, in which traditional cardiovascular risk factors, including HOMA-%S and BMI, were assessed at baseline, and echocardiographic determination of LVM and LV diastolic function was performed at follow-up. Associations between risk factors and echocardiographic variables were tested using multivariable linear and binary logistic regression. RESULTS: The study population comprised 247 men with a median (IQR) age of 47 (47–48) years. Mean (SD) BMI was 25.1 +/− 3.0 kg/m(2), and median (IQR) HOMA-%S was 113.0 (68.3–284.6). Subjects with low insulin sensitivity (lowest HOMA-%S quartile (Q1)) had significantly greater BMI, fasting plasma insulin, and higher fasting blood glucose (FBG) (p <0.02 for all). BMI and HOMA-%S were significantly correlated (r = −0.383, p <0.0001). At follow-up, mean (SD) LVM and LVMI were 202 +/− 61 g and 103 +/− 31 g/m(2), respectively, whereas median (IQR) E/é was 10 (8–12). Moreover, 36 % had grade 2 or 3 diastolic dysfunction. In multivariable analyses, greater BMI, but not low insulin sensitivity was independently associated with later detection of increased LVM and diastolic dysfunction. CONCLUSION: Greater baseline BMI, but not lower insulin sensitivity was independently associated with greater LVM and diastolic dysfunction at long-term follow-up. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12872-015-0165-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4676144 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46761442015-12-12 Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study Nielsen, Mette Lundgren Pareek, Manan Gerke, Oke Leósdóttir, Margrét Nilsson, Peter M. Olsen, Michael Hecht BMC Cardiovasc Disord Research Article BACKGROUND: To examine whether lower insulin sensitivity as determined by homeostatic model assessment (HOMA-%S) was associated with increased left ventricular mass (LVM) and presence of LV diastolic dysfunction at long-term follow-up, independently of body mass index (BMI), in middle-aged, otherwise healthy males. METHODS: Prospective population-based cohort study with a median (IQR) follow-up time of 28 (27–28) years, in which traditional cardiovascular risk factors, including HOMA-%S and BMI, were assessed at baseline, and echocardiographic determination of LVM and LV diastolic function was performed at follow-up. Associations between risk factors and echocardiographic variables were tested using multivariable linear and binary logistic regression. RESULTS: The study population comprised 247 men with a median (IQR) age of 47 (47–48) years. Mean (SD) BMI was 25.1 +/− 3.0 kg/m(2), and median (IQR) HOMA-%S was 113.0 (68.3–284.6). Subjects with low insulin sensitivity (lowest HOMA-%S quartile (Q1)) had significantly greater BMI, fasting plasma insulin, and higher fasting blood glucose (FBG) (p <0.02 for all). BMI and HOMA-%S were significantly correlated (r = −0.383, p <0.0001). At follow-up, mean (SD) LVM and LVMI were 202 +/− 61 g and 103 +/− 31 g/m(2), respectively, whereas median (IQR) E/é was 10 (8–12). Moreover, 36 % had grade 2 or 3 diastolic dysfunction. In multivariable analyses, greater BMI, but not low insulin sensitivity was independently associated with later detection of increased LVM and diastolic dysfunction. CONCLUSION: Greater baseline BMI, but not lower insulin sensitivity was independently associated with greater LVM and diastolic dysfunction at long-term follow-up. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12872-015-0165-3) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-10 /pmc/articles/PMC4676144/ /pubmed/26655187 http://dx.doi.org/10.1186/s12872-015-0165-3 Text en © Nielsen et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Nielsen, Mette Lundgren Pareek, Manan Gerke, Oke Leósdóttir, Margrét Nilsson, Peter M. Olsen, Michael Hecht Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title | Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title_full | Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title_fullStr | Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title_full_unstemmed | Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title_short | Greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
title_sort | greater body mass index is a better predictor of subclinical cardiac damage at long-term follow-up in men than is insulin sensitivity: a prospective, population-based cohort study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676144/ https://www.ncbi.nlm.nih.gov/pubmed/26655187 http://dx.doi.org/10.1186/s12872-015-0165-3 |
work_keys_str_mv | AT nielsenmettelundgren greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy AT pareekmanan greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy AT gerkeoke greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy AT leosdottirmargret greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy AT nilssonpeterm greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy AT olsenmichaelhecht greaterbodymassindexisabetterpredictorofsubclinicalcardiacdamageatlongtermfollowupinmenthanisinsulinsensitivityaprospectivepopulationbasedcohortstudy |